Latest On Nanosonics Limited (NNCSF):
About Nanosonics Limited (NNCSF):
Nanosonics Limited, together with its subsidiaries, engages in the research, development, and commercialization of infection control and decontamination products and related technologies. The company manufactures and distributes the trophon ultrasound probe disinfector, and its associated consumables and accessories for reducing cross-contamination between patients and the spread of healthcare acquired infections. It also provides trophon2, an ultrasound probe high level disinfection device; and trophon EPR, a device designed to disinfect intracavity and surface ultrasound probes. In addition, the company offers trophon EPR and trophon2 consumables and accessories, including NanoNebulant, a proprietary disinfectant liquid; trophon chemical indicators; trophon AcuTrace operator cards, medical instrument tags, printers, printer USB cables, printer label rolls, and logbooks; trophon wall mounts, printer wall mounts, carts, and printer cart mounts; trophon companion drying wipes and companion wipes wall mounts; clean ultrasound probe covers; and trophon AcuTrace PLUS activation cards. It operates in North America, Europe, the Middle East, and the Asia Pacific. The company was incorporated in 2000 and is headquartered in Lane Cove, Australia.
General
- Name Nanosonics Limited
- Symbol NNCSF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 311
- Fiscal Year EndJune
- Web URLhttp://www.nanosonics.com.au
Valuation
- Trailing PE 339.29
- Forward PE 222.22
- Price/Sales (Trailing 12 Mt.) 21.22
- Price/Book (Most Recent Quarter) 17.01
- Enterprise Value Revenue 16.47
- Enterprise Value EBITDA 129.61
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 6%
- Return on Assets 3%
- Return on Equity 5%
- Earnings Per Share $0.01
- Revenue Per Share $0
- Gross Profit 75.51 million
- Quarterly Earnings Growth -11.1%
Highlights
- Market Capitalization 1.44 billion
- Book Value Per Share $0.23
Share Statistics
- Shares Outstanding 301.08 million
- Shares Float 252.05 million
- % Held by Insiders 1809%
- % Held by Institutions 25.43%
Technicals
- Beta 1.33
- 52 Week High $6.17
- 52 Week Low $2.73
- 50 Day Moving Average 5.01
- 200 Day Moving Average 4.79
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Nanosonics Limited (NNCSF) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Nanosonics Limited (NNCSF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-12-31 | $N/A | $0.00 | $0.00 | |
2020-06-30 | 2020-09-30 | $N/A | $0.00 | $0.00 | |
2020-03-31 | 2020-06-30 | $N/A | $0.01 | $0.00 | |
2019-12-31 | 2020-03-31 | $24.26 million | $0.00 | $0.00 | |
2019-09-30 | 2019-12-31 | $24.26 million | $0.01 | $0.00 | |
2019-06-30 | 2019-09-30 | $21.82 million | $0.01 | $0.00 | |
2019-03-31 | 2019-06-30 | $21.82 million | $0.01 | $0.00 | |
2018-12-31 | 2019-03-31 | $20.35 million | $0.01 | $0.00 | |
2018-09-30 | 2018-12-31 | $20.35 million | $0.01 | $0.00 | |
2018-06-30 | 2018-09-30 | $15.34 million | $0.01 | $0.00 | |
2018-03-31 | 2018-06-30 | $15.34 million | $0.00 | $0.00 | |
2017-12-31 | 2018-03-31 | $15 million | $0.00 | $0.00 | |
2017-09-30 | 2017-12-31 | $15 million | $0.00 | $0.00 | |
2017-06-30 | 2017-09-30 | $15.69 million | $0.00 | $0.00 | |
2017-03-31 | 2017-06-30 | $15.69 million | $0.01 | $0.00 | |
2016-12-31 | 2017-03-31 | $18.06 million | $0.01 | $0.00 | |
2016-09-30 | 2016-12-31 | $18.06 million | $0.03 | $0.00 | |
2016-06-30 | 2016-09-30 | $0.03 | $0.00 | ||
2016-03-31 | 2016-06-30 | $0.00 | $0.00 | ||
2015-12-31 | 2016-03-31 | $0.00 | $0.00 | ||
2015-09-30 | 2015-12-31 | $-0.00 | $0.00 | ||
2015-06-30 | 2015-09-30 | $-0.00 | $0.00 | ||
2015-03-31 | 2015-06-30 | -$0.01 | $0.00 | ||
2014-12-31 | 2015-03-31 | -$0.01 | $0.00 | ||
2014-09-30 | 2014-12-31 | $0.00 | $0.00 | ||
2014-06-30 | 2014-09-30 | $0.00 | $0.00 | ||
2014-03-31 | 2014-06-30 | $0.00 | $0.00 | ||
2013-12-31 | 2014-03-31 | $0.00 | $0.00 | ||
2013-09-30 | 2013-12-31 | -$0.01 | $0.00 | ||
2013-06-30 | 2013-09-30 | -$0.01 | $0.00 | ||
2013-03-31 | 2013-06-30 | $0.00 | $0.00 | ||
2012-12-31 | 2013-03-31 | $0.00 | $0.00 | ||
2012-09-30 | 2012-12-31 | -$0.01 | $0.00 | ||
2012-06-30 | 2012-09-30 | -$0.01 | $0.00 | ||
2012-03-31 | 2012-06-30 | $-0.00 | $0.00 | ||
2011-12-31 | 2012-03-31 | $-0.00 | $0.00 | ||
2011-09-30 | 2011-12-31 | -$0.01 | $0.00 | ||
2011-06-30 | 2011-09-30 | -$0.01 | $0.00 | ||
2011-03-31 | 2011-06-30 | -$0.02 | $0.00 | ||
2010-12-31 | 2011-03-31 | -$0.02 | $0.00 | ||
2010-09-30 | 2010-12-31 | -$0.01 | $0.00 |
Nanosonics Limited (NNCSF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 |
---|---|---|---|---|---|
Research Development | N/A | N/A | N/A | N/A | N/A |
Income Before Tax | N/A | N/A | N/A | N/A | N/A |
Selling General Administrative | N/A | N/A | N/A | N/A | N/A |
Gross Profit | N/A | N/A | N/A | N/A | N/A |
Ebit | N/A | N/A | N/A | N/A | N/A |
Operating Income | N/A | N/A | N/A | N/A | N/A |
Income Tax Expense | -630500 | -630500 | 645000 | 645000 | 645000 |
Total Revenue | N/A | N/A | N/A | N/A | N/A |
Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
Total Other Income Expense Net | N/A | N/A | N/A | N/A | N/A |
Net Income From Continuing Operations | N/A | N/A | N/A | N/A | N/A |
Net Income Applicable to Common Shares | 732000 | 732000 | 2.21 million | 2.21 million | 2.21 million |
Cash Flow:
Date | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 | Jan 31 2020 | Dec 31 2019 |
---|---|---|---|---|---|
Investments | N/A | N/A | N/A | N/A | N/A |
Change to Liabilities | 952000 | 952000 | 952000 | 952000 | N/A |
Total Cash Flow from Investing Activities | -375000 | -375000 | -375000 | -375000 | -593000 |
Net Borrowings | -444000 | -444000 | -444000 | -444000 | -389500 |
Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | -187500 |
Change to Operating Activities | -1.43 million | -1.43 million | -1.43 million | -1.43 million | N/A |
Change in Cash | N/A | N/A | N/A | N/A | 4.89 million |
Total Cash from Operating Activities | 5.81 million | 5.81 million | 5.81 million | 5.81 million | 5.6 million |
Depreciation | N/A | N/A | N/A | N/A | 967500 |
Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
Change to Inventory | N/A | N/A | N/A | N/A | N/A |
Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
Other Cash Flow from Financing Activities | -25000 | -25000 | -25000 | -25000 | -30000 |
Change to Net Income | 427500 | 427500 | 427500 | 427500 | 1.78 million |
Capital Expenditures | N/A | N/A | N/A | N/A | 591000 |
Balance Sheet:
Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Apr 30 2020 | Mar 31 2020 |
---|---|---|---|---|---|
Total Liabailities | N/A | N/A | N/A | N/A | N/A |
Total Stockholder Equity | N/A | N/A | N/A | 227000 | N/A |
Other Current Liabilities | 5.19 million | 5.19 million | N/A | 124.23 million | N/A |
Total Assets | N/A | N/A | N/A | 158000 | N/A |
Common Stock | 113.38 million | 113.38 million | 113.18 million | N/A | 113.18 million |
Other Current Assets | 4.12 million | 4.12 million | N/A | 113.18 million | N/A |
Retained Earnings | -6 million | -6 million | -7.46 million | -7.46 million | -7.46 million |
Other Liabilities | 4.08 million | 4.08 million | 3.44 million | 3.44 million | 3.44 million |
Other Assets | 14.36 million | 14.36 million | 12.42 million | 12.42 million | 12.42 million |
Cash | N/A | N/A | N/A | 91.78 million | N/A |
Total Current Liabilities | 14.57 million | 14.57 million | N/A | 18.02 million | N/A |
Other Stockholder Equity | 22.97 million | 22.97 million | 18.51 million | 18.51 million | 18.51 million |
Property, Plant & Equipment | 8.98 million | 8.98 million | 9.62 million | 9.62 million | 9.62 million |
Total Current Assets | 126.62 million | 126.62 million | N/A | 124.55 million | N/A |
Long Term Investments | N/A | N/A | N/A | N/A | N/A |
Net Tangible Assets | 130.03 million | 130.03 million | 123.74 million | 123.74 million | 123.74 million |
Short Term Investments | N/A | N/A | N/A | N/A | N/A |
Long Term Debt | N/A | N/A | N/A | N/A | N/A |
Inventory | 12.31 million | 12.31 million | N/A | 11.84 million | N/A |
Accounts Payable | 5.17 million | 5.17 million | N/A | 3.39 million | N/A |
Nanosonics Limited (NNCSF) Chart:
Nanosonics Limited (NNCSF) News:
Below you will find a list of latest news for Nanosonics Limited (NNCSF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Nanosonics Limited (NNCSF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Nanosonics Limited (NNCSF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|